Coordinated effort of cooling after cardiac arrest may improve outcomes

Sunday, 5 February 2012, 19:22 | Category : Safety

Hypothermia is a very powerful treatment, but it was a very slow process for hospitals on board, said Dr. Benjamin Abella, assistant professor of emergency medicine and director of clinical research at the School of Medicine Perelman Center for the science of resuscitation at the University of Pennsylvania Medical Center in Philadelphia.

Progress against both fatal heart defect

Saturday, 4 February 2012, 20:02 | Category : Safety

Many near-normal exercise tolerance and do things most children, Ohye said.

The food tastes better through hard work

Friday, 3 February 2012, 6:22 | Category : Safety

The study was funded by grants from the National Institute of Diabetes and Digestive and Kidney Diseases and the National Institute of Mental Health.

Share tiny sea creatures found for “Diver Weight Belt” technique with the whales

Thursday, 2 February 2012, 15:12 | Category : Safety

Reports this week in the journal Limnology and Oceanography, the researchers describe how the British Antarctic Survey copepods Southern Ocean – the fish rich in omega-3 oil – ‘hibernate’ in the deep ocean during the winter when the sea is rough and poor food . To reach the depths of the ocean copepods oily liquid [...]

The discovery of Faint “Quark” Working with Heart Goes Viral physiologists

Wednesday, 25 January 2012, 21:11 | Category : Safety

Perhaps it is not yet ready for prime time news, but the publication of the discovery had a profound impact in the field of cardiac physiology, with more than 1,400 downloads of the journal Circulation Research in just one month, one of the highest ever according to the director Jonathan Schultz. The paper is the [...]

Once a day pill as effective as multiple doses of oral yeast infection of HIV / AIDS

Tuesday, 17 January 2012, 18:13 | Category : Safety

The study is considered the largest to date involving HIV / AIDS patients with OC. The infection is also common in patients suffering from various forms of cancer, particularly those with head and neck, where the infection rate is 77 % higher.

Provectus Reports on Second End of Phase 2 Meeting with FDA to define Pathway to Licensure of PV-10 for metastatic melanoma

Tuesday, 10 January 2012, 17:20 | Category : Safety

Craig Dees, Ph.D., CEO of Provectus said: “This meeting was extremely productive in defining the threshold of the agency requires for approval in oncology. Based on the recommendations of senior officials of the Agency at this meeting we propose to seek an end of phase 2 third meeting soon to finalize our project, because a [...]